Medical Group of Encino is a clinical research site located in Encino, California, United States 91436.
Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.
Medical Group of Encino has participated in 5 clinical trials.
Therapeutic areas: Type 2 Diabetes Mellitus, Diabetes Mellitus, Type II, Diabetes Mellitus, Non-Insulin-Dependent.
Sponsors: AstraZeneca, Halozyme Therapeutics, Eli Lilly and Company.
Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Medical Group of Encino has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Medical Group of Encino has 5 clinical trials on record. Their work covers Type 2 Diabetes Mellitus, Diabetes Mellitus, Type II, Diabetes Mellitus, Non-Insulin-Dependent.
Yes — Medical Group of Encino holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.